Next Article in Journal
Challenges for Natural Hydrogels in Tissue Engineering
Previous Article in Journal
From Microscale to Macroscale: Nine Orders of Magnitude for a Comprehensive Modeling of Hydrogels for Controlled Drug Delivery
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Commentary

Smart Bioinks as de novo Building Blocks to Bioengineer Living Tissues

by
Andreas Blaeser
1,
Sarah C. Heilshorn
2 and
Daniela F. Duarte Campos
2,*
1
Medical Textiles and Biofabrication, RWTH Aachen University, 52074 Aachen, Germany
2
Department of Materials Science & Engineering, Stanford University, Stanford, CA 94305, USA
*
Author to whom correspondence should be addressed.
Submission received: 6 April 2019 / Revised: 16 May 2019 / Accepted: 20 May 2019 / Published: 22 May 2019

1. Introduction

In vitro tissues and 3D in vitro models have come of age [1,2,3]. Engineered tissues can be used to substitute failed ones, such as skin [4] or cartilage [5], or as biotech microchips to predict the efficacy of new drugs against diseases, such as cancer [6,7]. In vitro models, fabricated by bioprinting or other additive manufacturing strategies, are valuable alternatives to state-of-the-art pre-clinical animal experiments, because they can be produced with patient-specific cells or humanized synthetic cells containing patient-specific genetic information. In vitro human models have two key advantages: (1) Animal experiments can be replaced, which is in accordance with global ethical guidelines and legal requirements proposed by current European regulations, and (2) in vitro human models may provide more accurate predictive values of actual human biology compared to animal models.
Hydrogels (often simply called gels) with embedded cells are the gold-standard materials used as bioinks in bioprinting [8,9]. Gels provide physical, chemical, and biological support to cells, which are embedded in the gels before, during, and after bioprinting. The use of compatible gels in bioprinting is essential for obtaining functional 3D tissues and must be viewed holistically to include biological, physical, and chemical perspectives. The design of a gel as bioink for bioprinting can be challenging and highly dependent on the intended tissue application (skeletal, gastro-intestinal, cardiovascular, neural, cancer, etc.).
Gels used in bioprinting can be of natural or synthetic origin [10,11]. Natural gels, such as collagen-based materials, are cell-compatible solutions for mimicking tissues containing collagen like cartilage, bone, skin, etc [12]. Fibrin-based gels have been extensively used for cardiovascular applications [13]. Recombinant elastin-like gels have been employed for cartilage and neural tissue engineering [14,15]. Interestingly, gels composed of synthetic polymers, such as polyethylene glycol (PEG) and poly-lactic acid (PLA), have also been used to create engineered mimics of many of these same tissue types, despite their different structural and chemical properties, compared to natural gels [16,17].
There are three fundamental aspects to be considered when designing smart bioinks to bioengineer in vitro tissues: Flow rheology, final matrix mechanics, and matrix biochemistry (Figure 1). Whereas the rheological properties of a bioink during flow are selected to be convenient before and during bioprinting, the final matrix mechanics and biochemistry are of critical importance to regulate cell phenotype after bioprinting. The ability to tweak and tune each one of these material properties is what ultimately defines the potential applications of each bioink. Recently, complex bioink formulations, comprising mixtures of natural and synthetic monomers, as well as functional additives, have been reported in an attempt to match the initial rheological, final mechanical, and biochemical demands of 3D bioprinting [8,18,19]. Although these gels provide excellent short-term results, it is unclear if they will allow long-term cellular adaptation and tissue maturation, such as in a living tissue. In the future, the incorporation of so-called “smart” material properties into bioinks may significantly improve the maturation and functionality of engineered tissues, by allowing the material to dynamically alter its properties over time to meet the changing needs of the embedded cells. “Smart” materials are defined as those whose properties can undergo significant changes in response to relatively small environmental triggers.

2. Tweaking the Flow Rheology

The rheological properties and gelation kinetics of a bioink determine its flow behavior, its sol-gel transition, and its viscoelastic response [20,21,22]. Controlling these factors is critical in reducing printing-related cell damage and enabling high printing precision [23]. Thus, thorough characterization of these properties and the ability to tweak them is highly desirable for robust bioinks. As an example, it is well known that the viscosity of a bioink can be altered by varying its monomer concentration or supplementing with additives. An ideal bioink must be engineered to have appropriate flow rheology, both during the printing process and immediately post-printing. In the future, this may require two distinct stages of rheological properties. For example, bioinks that shear-thin during the printing process, such as gelatin methacryloyl [24] and nanosilicate-loaded kappa-carrageenan [25], are developed for improving printability, shape retention, and cell viability during bioprinting. Hydrogels displaying many different types of non-Newtonian behavior (e.g., pseudoelastic, dilatant, and Bingham rheology) are routinely applied. Versatile bioink gelation mechanisms, including both physical (e.g., ionic/electrostatic/hydrophobic interactions, hydrogen bonding, or crystallization) and chemical (e.g., covalent bonding such as “click chemistry” and photopolymerization) crosslinking strategies have been developed [26,27]. Immediately post-printing, the bioink could be designed to have rapid gelation kinetics to improve the shape fidelity, as has been demonstrated by bioinks with enzymatic [28] and electrostatic [29] pre-crosslinking. Moreover, single- and dual-stage crosslinking bioinks, with distinct rheological properties during and after bioprinting, have shown both shear-thinning and self-healing behaviors, either via guest–host bonding with improved stabilization using photopolymerization (dual-stage crosslinking [30]) or oxidized alginate with imine type crosslinks (single-stage crosslinking [31]).
In the future, smart hydrogels could be designed to not only allow printability, but to enable reversible switching of rheological properties. This type of exquisite control over flow rheology may be useful, for example, when printing complex, hierarchical structures that require different levels of print resolution, and hence different ink viscosities, in different regions of the printed construct. Recent studies have demonstrated the feasibility of this idea. For example, Accardo and Kalow developed a dynamic hydrogel with reversible viscoelasticity by irradiating hydrogels bearing azobenzene-boronic acid and diol end groups with two different wavelengths of light [32]. Chu and Feng reported smart micelle fluids, which exhibit stimuli-responsive alterations of their viscosity profile [33]. Although these specific materials have not yet been demonstrated to be cell-compatible, their design strategies suggest that similar concepts could be transferred to smart bioink development.

3. Tuning the Final Matrix Mechanics

Following bioprinting, cell-containing bioinks are cultured for several days or weeks with the goal to fabricate living tissue [34,35]. Many groups have demonstrated that the mechanics of the cellular microenvironment can impact several cell behaviors, including proliferation, migration, differentiation, and fate [36]. While this observation was originally reported for elastic-like gels displaying a time-independent stiffness, it is now known that time-dependent mechanical properties (i.e. viscoelasticity) also impact cell behavior [37,38,39]. Hydrogels that provide poor or contradicting mechanical signals, with respect to cell function over time, may demonstrate successful short-term results (e.g., cell encapsulation) but may not support long-term transformation towards the desired tissue or organ mimic. A common dilemma in these systems is that it can be challenging to engineer a material that has the necessary biologically relevant stiffness without inhibiting cell spreading and migration. Adaptable hydrogels offer a potential solution to this conflict of objectives. Adaptable hydrogels are networks that can reversibly crosslink, giving cells the freedom to spread, migrate, and proliferate without degrading the material. For example, many types of dynamic covalent bonds have been used to crosslink biopolymers, including PEG and proteins [40]. Encapsulated cells in these dynamic hydrogels often show varying morphological changes, depending on the rate of stress relaxation [40]. This idea has recently been demonstrated in a printable bioink that uses dynamic covalent bonds to alter the matrix stress relaxation rate and hence the amount of cell spreading [31]. This approach may be ideal for designing bioprinted tissues, although further development will be necessary to ensure the 3D-printed shapes can be maintained for longer incubation periods.
Besides structural integrity and cell fate determination, bioink mechanics play an important role in dynamic conditioning of tissues. In response to external forces exerted in shearing [41], compressing [42], or stretching bioreactors [43], biomimetic tissue formation can be observed. In the future, smart bioinks may enable more efficient application of mechanical stimulation to encapsulated cells. Local alteration of the gel mechanical properties could be used to exert forces onto cells. This can be achieved, for instance, by integration of light, electric, or magnetic responsive particles or polymers into bioinks [44,45,46,47].
It should also be noted that several bioinks currently in use do not allow independent variation of both the matrix mechanical and biochemical properties. For example, when polymer concentration is used to increase the matrix biomechanics, this also increases the concentration of cell-adhesive binding ligands, altering cell biochemistry. Similarly, some bioinks use the addition of fillers, such as nanocellulose [48] or nanoclay [49,50] to increase matrix mechanics. However, these changes directly affect the porosity and topographical structure of the network, thereby altering the local presentation of cell-adhesive binding ligands, which affects cell adhesion, migration, and proliferation potential. Fortunately, many examples exist in the broader biomaterials literature where innovative materials have been designed to decouple these two matrix properties, and these design strategies could be further adopted by the bioprinting community. Accordingly, one area of promise for future bioink development is the design of smart materials that enable the decoupled tuning of ink mechanics and biochemistry. Chemical modification of polysaccharide backbones, e.g., by carboxylation [18,51,52] or sequential hydrogel crosslinking [53], are recent examples, showing how this goal could be achieved.

4. Engineering the Biochemistry

Biocompatibility, molecular recognition, and functionality are the properties that confer biomimicry to 3D bioengineered tissues. As a minimum requirement, all reagents and materials used during bioprinting should be biocompatible. Importantly, some reagents, such as photoinitiators, may be cell compatible at shorter times, but toxic to cells at longer times. Thus, the choice of bioink chemistry can restrict the printing process. Several studies have demonstrated approaches to integrate native elements of molecular recognition into 3D hydrogel cultures, which can be directly transferred and applied to bioinks. A common strategy is to include peptide and protein molecules found in the natural extracellular matrix into engineered bioinks. These molecular recognition motifs enable cell-surface receptors to bind to the bioink, enabling cell-detection of matrix mechanics. A newer concept is the incorporation of DNA molecules into a bioink, either as the polymer backbone or a cross-linker that connects the main building blocks [54]. DNA-derived bioinks can be designed with stimuli-responsive properties in order to tune the rheological, final mechanical, and biochemical characteristics of the material. For example, a recent study presented a DNA hydrogel capable of producing RNA and interfering with protein expression [55]. Cells encapsulated in this gel were able to internalize and engulf the DNA gel by receptor-mediated endocytosis. Prospectively, DNA can be synthesized into specifically designed sequences for the 3D printing of personalized implants for therapeutic gene editing [56].
Besides molecular recognition, other material functionality can play an important role in mimicking artificial tissues. For example, in cardiovascular and neural research it may be necessary to consider the electroconductivity of the chosen bioink. In line with this, electroconductive hydrogels with functional pendant groups have been synthesized, showing responsive electroactivity in physiological conditions [50,57]. These functionally smart hydrogels have been used as cardiac patches in preliminary in vivo studies, showing their compatibility with the rhythmogenic activity of the heart [58].

5. The Last Piece of the Puzzle: Living Cells for Living Tissues

Bioprinting is defined as the manufacturing of complex 3D constructs, using a combination of living cells and biomaterial inks. The living cell could be either of human or animal (murine, ovine, canine, etc.) origination. Logically, bioengineered human tissues and organs are valuable for human regenerative medicine, whereas animal-based tissues are relevant in veterinary medicine and as models of human disease. Attempts to fabricate human blood vessels, heart, liver, cornea, and cartilage were done using human primary endothelial cells [59], cardiomyocytes [60], hepatocytes [61], keratocytes [62], and chondrocytes [63]. Besides primary adult cells, stem cells [64,65], pre-differentiated cells [14], and organoids [66,67,68] were used for bioprinting applications and have great potential.
Considering the use of bioprinted in vitro models as diagnostic tools, one could consider advancing from traditionally utilized mammalian cells to synthetic biology. New-generation diagnostic tools could potentially provide new ways to dynamically probe and monitor human pathobiology. In line with this, and as an exciting alternative to mammalian cells, synthetic protocells could potentially be encapsulated into smart bioinks as a replacement to human and animal cells to develop complex 3D artificial tissues. An artificial protocell is a synthetic, cell-like structure, consisting of a phospholipid bilayer membrane that encapsulates molecular components found in natural cells, such as synthetic DNA and enzymatic machines. Artificial cells can be synthesized using only non-living components. Recently, artificial protocells were synthesized with enough genetic information to self-replicate and maintain some basic cellular functions, such as molecular self-organization [69,70]. In the future, synthetic biology morphogenetic mechanisms, such as patterning by phase separation, may allow the construction of an artificial “developmental cycle” by invoking cell proliferation, fusion, migration, and differentiation through changes in gene expression [71]. In one potential application, artificial tissues could sense and adapt to their surroundings, and, thus, deliver drugs more precisely to their targets. Although still an emerging technology, synthetic cell biology offers tremendous potential for use in 3D bioprinting of tissues.

6. Concluding Remarks

Research on cell patterning and bioprinting dates to the beginning of the 21st century. Technological questions led the debate in the early stages of bioprinting research. Is it feasible to print living cells? What are the boundary conditions for a safe cell-substrate transfer? Which methods can be used to assemble cells and biomaterials (e.g., microextrusion, inkjet, laser-assisted)? In parallel, research groups began to shed light on basic biomaterial questions. What environments enable 3D cell culture? Is it possible to design 3D-bioprintable materials without causing cell damage? Is it possible to modulate viscoelasticity in order to favor cell-matrix interactions? These requirements for the ink material continue to increase over time, and gels that simply encapsulate living cells and are permissive of bioprinting will be substituted by bioinks that support short-term and long-term cellular demands.
Within the last two decades, tremendous advances have been made in the development of 3D bioprinting, and many materials that are both cell-compatible and printable have been reported. Hydrogels that meet these two key requirements are now considered to be excellent bioinks; however, future development of smart bioinks is poised to push the field further. Besides simply providing the necessary flow rheology, final matrix mechanics, and matrix biochemistry to achieve viable cell culture and printability, smart bioinks will enable dynamic manipulation of these terms. Smart hydrogels can potentially interact with living organisms through reciprocal feedback, where the hydrogel instructs the organism and the organism causes the hydrogel to adapt. Thus, future bioinks may be able to adapt and “mature” along with the maturation of encapsulated cells to form truly functional tissue. Combining dynamic control of hydrogel mechanics and biochemistry with the advancing research on synthetic biology, artificial tissues created using smart bioinks will form a new class of person-made tissues. Projecting this thought into the future, visionary smart bioinks will provide a symbiotic environment for dynamic, responsive interactions between the synthetic matrix and the encapsulated cells. In these newly bioinspired ecosystems, the roles and tasks of cells and biomaterials will be newly defined.

Author Contributions

Conceptualization, A.B. and D.F.D.C.; Formal Analysis, A.B., S.C.H. and D.F.D.C.; Writing-Original Draft Preparation, A.B., S.C.H. and D.F.D.C.; Writing-Review & Editing, A.B., S.C.H. and D.F.D.C.; Funding Acquisition, A.B., S.C.H. and D.F.D.C.

Funding

The authors acknowledge support from the National Science Foundation (DMR-1808415 to S.C.H.), the National Institutes of Health (R01-HL142718 to S.C.H.), the German Research Foundation (DFG-425869082 to D.F.D.C.), and the Excellence Initiative of the German Federal and State Governments (ERS SeedFund-OPSF470 to A.B.).

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Bray, L.J.; Werner, C. Evaluation of Three-Dimensional In Vitro Models to Study Tumor Angiogenesis. ACS Biomater. Sci. Eng. 2018, 4, 337–346. [Google Scholar] [CrossRef]
  2. Kang, H.-W.; Lee, S.J.; Ko, I.K.; Kengla, C.; Yoo, J.J.; Atala, A. A 3D bioprinting system to produce human-scale tissue constructs with structural integrity. Nat. Biotechnol. 2016, 34, 312–319. [Google Scholar] [CrossRef]
  3. Shamir, E.R.; Ewald, A.J. Three-dimensional organotypic culture: experimental models of mammalian biology and disease. Nat. Rev. Mol. Cell Biol. 2014, 15, 647–664. [Google Scholar] [CrossRef]
  4. Lee, V.; Singh, G.; Trasatti, J.P.; Bjornsson, C.; Xu, X.; Tran, T.N.; Yoo, S.-S.; Dai, G.; Karande, P. Design and Fabrication of Human Skin by Three-Dimensional Bioprinting. Tissue Eng. Part C. Methods 2013. [Google Scholar] [CrossRef]
  5. Betsch, M.; Cristian, C.; Lin, Y.-Y.; Blaeser, A.; Schöneberg, J.; Vogt, M.; Buhl, E.M.; Fischer, H.; Duarte Campos, D.F. Incorporating 4D into Bioprinting: Real-Time Magnetically Directed Collagen Fiber Alignment for Generating Complex Multilayered Tissues. Adv. Healthc. Mater. 2018, 7, 1800894. [Google Scholar] [CrossRef]
  6. Meijer, T.G.; Naipal, K.A.; Jager, A.; van Gent, D.C. Ex Vivo tumor culture systems for functional drug testing and therapy response prediction. Futur. Sci. OA 2017, 3, FSO190. [Google Scholar] [CrossRef] [PubMed]
  7. Katt, M.E.; Placone, A.L.; Wong, A.D.; Xu, Z.S.; Searson, P.C. In Vitro Tumor Models: Advantages, Disadvantages, Variables, and Selecting the Right Platform. Front. Bioeng. Biotechnol. 2016, 4, 12. [Google Scholar] [CrossRef] [PubMed]
  8. Levato, R.; Webb, W.R.; Otto, I.A.; Mensinga, A.; Zhang, Y.; van Rijen, M.; van Weeren, R.; Khan, I.M.; Malda, J. The bio in the ink: cartilage regeneration with bioprintable hydrogels and articular cartilage-derived progenitor cells. Acta Biomater. 2017, 61, 41–53. [Google Scholar] [CrossRef] [Green Version]
  9. Malda, J.; Visser, J.; Melchels, F.P.; Jüngst, T.; Hennink, W.E.; Dhert, W.J.A.; Groll, J.; Hutmacher, D.W. 25th Anniversary Article: Engineering Hydrogels for Biofabrication. Adv. Mater. 2013, 25, 5011–5028. [Google Scholar] [CrossRef] [PubMed]
  10. Gasperini, L.; Mano, J.F.; Reis, R.L. Natural polymers for the microencapsulation of cells. J. R. Soc. Interface 2014, 11, 20140817. [Google Scholar] [CrossRef] [Green Version]
  11. Almany, L.; Seliktar, D. Biosynthetic hydrogel scaffolds made from fibrinogen and polyethylene glycol for 3D cell cultures. Biomaterials 2005, 26, 2467–2477. [Google Scholar] [CrossRef] [PubMed]
  12. Duarte Campos, D.F.; Blaeser, A.; Korsten, A.; Neuss, S.; Jäkel, J.; Vogt, M.; Fischer, H. The stiffness and structure of three-dimensional printed hydrogels direct the differentiation of mesenchymal stromal cells toward adipogenic and osteogenic lineages. Tissue Eng. Part A 2015, 21, 740–756. [Google Scholar] [CrossRef]
  13. Pankajakshan, D.; Krishnan V, K.; Krishnan, L.K. Functional stability of endothelial cells on a novel hybrid scaffold for vascular tissue engineering. Biofabrication 2010, 2, 041001. [Google Scholar] [CrossRef]
  14. Madl, C.M.; Lesavage, B.L.; Dewi, R.E.; Dinh, C.B.; Stowers, R.S.; Khariton, M.; Lampe, K.J.; Nguyen, D.; Chaudhuri, O.; Enejder, A.; et al. Maintenance of neural progenitor cell stemness in 3D hydrogels requires matrix remodelling. Nat. Mater. 2017, 16, 1233–1242. [Google Scholar] [CrossRef] [Green Version]
  15. Wang, H.; Zhu, D.; Paul, A.; Cai, L.; Enejder, A.; Yang, F.; Heilshorn, S.C. Covalently Adaptable Elastin-Like Protein-Hyaluronic Acid (ELP-HA) Hybrid Hydrogels with Secondary Thermoresponsive Crosslinking for Injectable Stem Cell Delivery. Adv. Funct. Mater. 2017, 27, 1605609. [Google Scholar] [CrossRef]
  16. Omidinia-Anarkoli, A.; Boesveld, S.; Tuvshindorj, U.; Rose, J.C.; Haraszti, T.; De Laporte, L. An Injectable Hybrid Hydrogel with Oriented Short Fibers Induces Unidirectional Growth of Functional Nerve Cells. Small 2017, 13, 1702207. [Google Scholar] [CrossRef]
  17. Rose, J.C.; Cámara-Torres, M.; Rahimi, K.; Köhler, J.; Möller, M.; De Laporte, L. Nerve Cells Decide to Orient inside an Injectable Hydrogel with Minimal Structural Guidance. Nano Lett. 2017, 17, 3782–3791. [Google Scholar] [CrossRef]
  18. Forget, A.; Christensen, J.; Lüdeke, S.; Kohler, E.; Tobias, S.; Matloubi, M.; Thomann, R.; Shastri, V.P. Polysaccharide hydrogels with tunable stiffness and provasculogenic properties via α-helix to β-sheet switch in secondary structure. Proc. Natl. Acad. Sci. USA 2013, 110, 12887–12892. [Google Scholar] [CrossRef]
  19. Morouço, P.; Lattanzi, W.; Alves, N. Four-Dimensional Bioprinting As a New Era for Tissue Engineering and Regenerative Medicine. Front. Bioeng. Biotechnol. 2017, 5, 61. [Google Scholar] [CrossRef]
  20. Sacco, P.; Borgogna, M.; Travan, A.; Marsich, E.; Paoletti, S.; Asaro, F.; Grassi, M.; Donati, I. Polysaccharide-based networks from homogeneous chitosan-tripolyphosphate hydrogels: synthesis and characterization. Biomacromolecules 2014, 15, 3396–3405. [Google Scholar] [CrossRef]
  21. Aymard, P.; Martin, D.R.; Plucknett, K.; Foster, T.J.; Clark, A.H.; Norton, I.T. Influence of thermal history on the structural and mechanical properties of agarose gels. Biopolymers 2001, 59, 131–144. [Google Scholar] [CrossRef]
  22. Weng, L.; Chen, X.; Chen, W. Rheological characterization of in situ crosslinkable hydrogels formulated from oxidized dextran and N-carboxyethyl chitosan. Biomacromolecules 2007, 8, 1109–1115. [Google Scholar] [CrossRef]
  23. Blaeser, A.; Duarte Campos, D.F.; Puster, U.; Richtering, W.; Stevens, M.M.; Fischer, H. Controlling Shear Stress in 3D Bioprinting is a Key Factor to Balance Printing Resolution and Stem Cell Integrity. Adv. Healthc. Mater. 2015. [Google Scholar] [CrossRef]
  24. Liu, W.; Heinrich, M.A.; Zhou, Y.; Akpek, A.; Hu, N.; Liu, X.; Guan, X.; Zhong, Z.; Jin, X.; Khademhosseini, A.; et al. Extrusion Bioprinting of Shear-Thinning Gelatin Methacryloyl Bioinks. Adv. Healthc. Mater. 2017, 6. [Google Scholar] [CrossRef]
  25. Wilson, S.A.; Cross, L.M.; Peak, C.W.; Gaharwar, A.K. Shear-Thinning and Thermo-Reversible Nanoengineered Inks for 3D Bioprinting. ACS Appl. Mater. Interfaces 2017, 9, 43449–43458. [Google Scholar] [CrossRef]
  26. Peppas, N.A.; Hilt, J.Z.; Khademhosseini, A.; Langer, R. Hydrogels in Biology and Medicine: From Molecular Principles to Bionanotechnology. Adv. Mater. 2006, 18, 1345–1360. [Google Scholar] [CrossRef]
  27. Hu, W.; Wang, Z.; Xiao, Y.; Zhang, S.; Wang, J. Advances in crosslinking strategies of biomedical hydrogels. Biomater. Sci. 2019, 7, 843–855. [Google Scholar] [CrossRef]
  28. Petta, D.; Armiento, A.R.; Grijpma, D.; Alini, M.; Eglin, D.; D’Este, M. 3D bioprinting of a hyaluronan bioink through enzymatic-and visible light-crosslinking. Biofabrication 2018, 10, 044104. [Google Scholar] [CrossRef]
  29. Dubbin, K.; Tabet, A.; Heilshorn, S.C. Quantitative criteria to benchmark new and existing bio-inks for cell compatibility. Biofabrication 2017, 9, 044102. [Google Scholar] [CrossRef]
  30. Ouyang, L.; Highley, C.B.; Rodell, C.B.; Sun, W.; Burdick, J.A. 3D Printing of Shear-Thinning Hyaluronic Acid Hydrogels with Secondary Cross-Linking. ACS Biomater. Sci. Eng. 2016, 2, 1743–1751. [Google Scholar] [CrossRef]
  31. Hafeez, S.; Ooi, H.; Morgan, F.; Mota, C.; Dettin, M.; van Blitterswijk, C.; Moroni, L.; Baker, M.; Hafeez, S.; Ooi, H.W.; et al. Viscoelastic Oxidized Alginates with Reversible Imine Type Crosslinks: Self-Healing, Injectable, and Bioprintable Hydrogels. Gels 2018, 4, 85. [Google Scholar] [CrossRef]
  32. Accardo, J.V.; Kalow, J.A. Reversibly tuning hydrogel stiffness through photocontrolled dynamic covalent crosslinks. Chem. Sci. 2018, 9, 5987–5993. [Google Scholar] [CrossRef] [Green Version]
  33. Chu, Z.; Feng, Y. pH-switchable wormlike micelles. Chem. Commun. 2010, 46, 9028. [Google Scholar] [CrossRef]
  34. Duarte Campos, D.F.; Blaeser, A.; Weber, M.; Jäkel, J.; Neuss, S.; Jahnen-Dechent, W.; Fischer, H. Three-dimensional printing of stem cell-laden hydrogels submerged in a hydrophobic high-density fluid. Biofabrication 2013, 5, 015003. [Google Scholar] [CrossRef]
  35. Blaeser, A.; Duarte Campos, D.F.; Weber, M.; Neuss, S.; Theek, B.; Fischer, H.; Jahnen-Dechent, W. Biofabrication under fluorocarbon: a novel freeform fabrication technique to generate high aspect ratio tissue-engineered constructs. Biores. Open Access 2013, 2, 374–384. [Google Scholar] [CrossRef]
  36. Engler, A.J.; Sen, S.; Sweeney, H.L.; Discher, D.E. Matrix Elasticity Directs Stem Cell Lineage Specification. Cell 2006, 126, 677–689. [Google Scholar] [CrossRef] [Green Version]
  37. Cameron, A.R.; Frith, J.E.; Cooper-White, J.J. The influence of substrate creep on mesenchymal stem cell behaviour and phenotype. Biomaterials 2011, 32, 5979–5993. [Google Scholar] [CrossRef]
  38. Chaudhuri, O.; Gu, L.; Klumpers, D.; Darnell, M.; Bencherif, S.A.; Weaver, J.C.; Huebsch, N.; Lee, H.-P.; Lippens, E.; Duda, G.N.; et al. Hydrogels with tunable stress relaxation regulate stem cell fate and activity. Nat. Mater. 2016, 15, 326–334. [Google Scholar] [CrossRef]
  39. Chaudhuri, O. Viscoelastic hydrogels for 3D cell culture. Biomater. Sci. 2017, 5, 1480–1490. [Google Scholar] [CrossRef]
  40. Wang, H.; Heilshorn, S.C. Adaptable Hydrogel Networks with Reversible Linkages for Tissue Engineering. Adv. Mater. 2015, 27, 3717–3736. [Google Scholar] [CrossRef]
  41. Wolf, F.; Rojas González, D.M.; Steinseifer, U.; Obdenbusch, M.; Herfs, W.; Brecher, C.; Jockenhoevel, S.; Mela, P.; Schmitz-Rode, T. VascuTrainer: A Mobile and Disposable Bioreactor System for the Conditioning of Tissue-Engineered Vascular Grafts. Ann. Biomed. Eng. 2018, 46, 616–626. [Google Scholar] [CrossRef]
  42. Seo, J.; Shin, J.-Y.; Leijten, J.; Jeon, O.; Bal Öztürk, A.; Rouwkema, J.; Li, Y.; Shin, S.R.; Hajiali, H.; Alsberg, E.; et al. Interconnectable Dynamic Compression Bioreactors for Combinatorial Screening of Cell Mechanobiology in Three Dimensions. ACS Appl. Mater. Interfaces 2018, 10, 13293–13303. [Google Scholar] [CrossRef] [PubMed]
  43. Hogan, M.; Chen, Y.-T.; Kolhatkar, A.G.; Candelari, C.J.; Madala, S.; Lee, T.R.; Birla, R. Conditioning of Cardiovascular Tissue Using a Noncontact Magnetic Stretch Bioreactor with Embedded Magnetic Nanoparticles. ACS Biomater. Sci. Eng. 2016, 2, 1619–1629. [Google Scholar] [CrossRef]
  44. Tognato, R.; Armiento, A.R.; Bonfrate, V.; Levato, R.; Malda, J.; Alini, M.; Eglin, D.; Giancane, G.; Serra, T. A Stimuli-Responsive Nanocomposite for 3D Anisotropic Cell-Guidance and Magnetic Soft Robotics. Adv. Funct. Mater. 2019, 29, 1804647. [Google Scholar] [CrossRef]
  45. Antman-Passig, M.; Shefi, O. Remote Magnetic Orientation of 3D Collagen Hydrogels for Directed Neuronal Regeneration. Nano Lett. 2016, 16, 2567–2573. [Google Scholar] [CrossRef]
  46. Skardal, A.; Zhang, J.; McCoard, L.; Xu, X.; Oottamasathien, S.; Prestwich, G.D. Photocrosslinkable hyaluronan-gelatin hydrogels for two-step bioprinting. Tissue Eng. Part A 2010, 16, 2675–2685. [Google Scholar] [CrossRef]
  47. Freeman, F.E.; Kelly, D.J. Tuning Alginate Bioink Stiffness and Composition for Controlled Growth Factor Delivery and to Spatially Direct MSC Fate within Bioprinted Tissues. Sci. Rep. 2017, 7, 17042. [Google Scholar] [CrossRef]
  48. Piras, C.C.; Fernández-Prieto, S.; De Borggraeve, W.M. Nanocellulosic materials as bioinks for 3D bioprinting. Biomater. Sci. 2017, 5, 1988–1992. [Google Scholar] [CrossRef]
  49. Hasany, M.; Thakur, A.; Taebnia, N.; Kadumudi, F.B.; Shahbazi, M.-A.; Pierchala, M.K.; Mohanty, S.; Orive, G.; Andresen, T.L.; Foldager, C.B.; et al. Combinatorial Screening of Nanoclay-Reinforced Hydrogels: A Glimpse of the “Holy Grail” in Orthopedic Stem Cell Therapy? ACS Appl. Mater. Interfaces 2018, 10, 34924–34941. [Google Scholar] [CrossRef]
  50. Tondera, C.; Akbar, T.F.; Thomas, A.K.; Lin, W.; Werner, C.; Busskamp, V.; Zhang, Y.; Minev, I.R. Highly Conductive, Stretchable, and Cell-Adhesive Hydrogel by Nanoclay Doping. Small 2019, 1901406. [Google Scholar] [CrossRef] [PubMed]
  51. Forget, A.; Pique, R.-A.; Ahmadi, V.; Lüdeke, S.; Shastri, V.P. Mechanically Tailored Agarose Hydrogels through Molecular Alloying with β-Sheet Polysaccharides. Macromol. Rapid Commun. 2015, 36, 196–203. [Google Scholar] [CrossRef] [PubMed]
  52. Forget, A.; Blaeser, A.; Miessmer, F.; Köpf, M.; Duarte Campos, D.F.; Voelcker, N.H.; Blencowe, A.; Fischer, H.; Shastri, V.P. Mechanically Tunable Bioink for 3D Bioprinting of Human Cells. Adv. Healthc. Mater. 2017, 6. [Google Scholar] [CrossRef]
  53. Vining, K.H.; Stafford, A.; Mooney, D.J. Sequential modes of crosslinking tune viscoelasticity of cell-instructive hydrogels. Biomaterials 2019, 188, 187–197. [Google Scholar] [CrossRef] [PubMed]
  54. Shahbazi, M.-A.; Bauleth-Ramos, T.; Santos, H.A. DNA Hydrogel Assemblies: Bridging Synthesis Principles to Biomedical Applications. Adv. Ther. 2018, 1, 1800042. [Google Scholar] [CrossRef]
  55. Song, J.; Lee, M.; Kim, T.; Na, J.; Jung, Y.; Jung, G.Y.; Kim, S.; Park, N. A RNA producing DNA hydrogel as a platform for a high performance RNA interference system. Nat. Commun. 2018, 9, 4331. [Google Scholar] [CrossRef] [PubMed]
  56. Chen, Z.; Liu, F.; Chen, Y.; Liu, J.; Wang, X.; Chen, A.T.; Deng, G.; Zhang, H.; Liu, J.; Hong, Z.; et al. Targeted Delivery of CRISPR/Cas9-Mediated Cancer Gene Therapy via Liposome-Templated Hydrogel Nanoparticles. Adv. Funct. Mater. 2017, 27, 1703036. [Google Scholar] [CrossRef]
  57. Mawad, D.; Artzy-Schnirman, A.; Tonkin, J.; Ramos, J.; Inal, S.; Mahat, M.M.; Darwish, N.; Zwi-Dantsis, L.; Malliaras, G.G.; Justin Gooding, J.; et al. Electroconductive Hydrogel Based on Functional Poly(Ethylenedioxy Thiophene). Chem. Mater. 2016, 28, 6080–6088. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  58. Mawad, D.; Mansfield, C.; Lauto, A.; Perbellini, F.; Nelson, G.W.; Tonkin, J.; Bello, S.O.; Carrad, D.J.; Micolich, A.P.; Mahat, M.M.; et al. A conducting polymer with enhanced electronic stability applied in cardiac models. Sci. Adv. 2016, 2, e1601007. [Google Scholar] [CrossRef]
  59. Kreimendahl, F.; Köpf, M.; Thiebes, A.L.; Duarte Campos, D.F.; Blaeser, A.; Schmitz-Rode, T.; Apel, C.; Jockenhoevel, S.; Fischer, H. Three-Dimensional Printing and Angiogenesis: Tailored Agarose-Type I Collagen Blends Comprise Three-Dimensional Printability and Angiogenesis Potential for Tissue-Engineered Substitutes. Tissue Eng. Part C Methods 2017, 23, 604–615. [Google Scholar] [CrossRef]
  60. Chan, V.; Jeong, J.H.; Bajaj, P.; Collens, M.; Saif, T.; Kong, H.; Bashir, R. Multi-material bio-fabrication of hydrogel cantilevers and actuators with stereolithography. Lab Chip 2012, 12, 88–98. [Google Scholar] [CrossRef]
  61. Zhang, Y.S.; Yue, K.; Aleman, J.; Moghaddam, K.M.; Bakht, S.M.; Yang, J.; Jia, W.; Dell’Erba, V.; Assawes, P.; Shin, S.R.; et al. 3D Bioprinting for Tissue and Organ Fabrication. Ann. Biomed. Eng. 2017, 45, 148–163. [Google Scholar] [CrossRef] [PubMed]
  62. Duarte Campos, D.F.; Rohde, M.; Ross, M.; Anvari, P.; Blaeser, A.; Vogt, M.; Panfil, C.; Yam, G.H.; Mehta, J.S.; Fischer, H.; et al. Corneal bioprinting utilizing collagen-based bioinks and primary human keratocytes. J. Biomed. Mater. Res. Part A 2019. [Google Scholar] [CrossRef] [PubMed]
  63. Duarte Campos, D.F.; Philip, M.A.; Gürzing, S.; Melcher, C.; Lin, Y.Y.; Schöneberg, J.; Blaeser, A.; Theek, B.; Fischer, H.; Betsch, M. Synchronized Dual Bioprinting of Bioinks and Biomaterial Inks as a Translational Strategy for Cartilage Tissue Engineering. 3D Print. Addit. Manuf. 2019, 6, 63–71. [Google Scholar] [CrossRef]
  64. Sorkio, A.; Koch, L.; Koivusalo, L.; Deiwick, A.; Miettinen, S.; Chichkov, B.; Skottman, H. Human stem cell based corneal tissue mimicking structures using laser-assisted 3D bioprinting and functional bioinks. Biomaterials 2018, 171, 57–71. [Google Scholar] [CrossRef] [PubMed]
  65. Duarte Campos, D.F.; Blaeser, A.; Buellesbach, K.; Sen, K.S.; Xun, W.; Tillmann, W.; Fischer, H. Bioprinting Organotypic Hydrogels with Improved Mesenchymal Stem Cell Remodeling and Mineralization Properties for Bone Tissue Engineering. Adv. Healthc. Mater. 2016. [Google Scholar] [CrossRef] [PubMed]
  66. Zhao, H.; Chen, Y.; Shao, L.; Xie, M.; Nie, J.; Qiu, J.; Zhao, P.; Ramezani, H.; Fu, J.; Ouyang, H.; et al. Airflow-Assisted 3D Bioprinting of Human Heterogeneous Microspheroidal Organoids with Microfluidic Nozzle. Small 2018, 14, 1802630. [Google Scholar] [CrossRef] [PubMed]
  67. Rodrigues, T.; Kundu, B.; Silva-Correia, J.; Kundu, S.C.; Oliveira, J.M.; Reis, R.L.; Correlo, V.M. Emerging tumor spheroids technologies for 3D in vitro cancer modeling. Pharmacol. Ther. 2018, 184, 201–211. [Google Scholar] [CrossRef]
  68. Schneeberger, K.; Spee, B.; Costa, P.; Sachs, N.; Clevers, H.; Malda, J. Converging biofabrication and organoid technologies: the next frontier in hepatic and intestinal tissue engineering? Biofabrication 2017, 9, 013001. [Google Scholar] [CrossRef] [PubMed]
  69. Göpfrich, K.; Platzman, I.; Spatz, J.P. Mastering Complexity: Towards Bottom-up Construction of Multifunctional Eukaryotic Synthetic Cells. Trends Biotechnol. 2018, 36, 938–951. [Google Scholar] [CrossRef] [Green Version]
  70. Elani, Y.; Trantidou, T.; Wylie, D.; Dekker, L.; Polizzi, K.; Law, R.V.; Ces, O. Constructing vesicle-based artificial cells with embedded living cells as organelle-like modules. Sci. Rep. 2018, 8, 4564. [Google Scholar] [CrossRef]
  71. Davies, J.A.; Cachat, E. Synthetic biology meets tissue engineering. Biochem. Soc. Trans. 2016, 44, 696–701. [Google Scholar] [CrossRef] [PubMed]
Figure 1. Smart hydrogels suitable for bioprinting to bioengineer tissues and organs. The flow rheology, matrix mechanics, and matrix biochemistry of the bioinks can be tuned to mimic the desired characteristics of native tissue. Human cells or humanized synthetic protocells contribute to making 3D bioprinted tissues living and functional.
Figure 1. Smart hydrogels suitable for bioprinting to bioengineer tissues and organs. The flow rheology, matrix mechanics, and matrix biochemistry of the bioinks can be tuned to mimic the desired characteristics of native tissue. Human cells or humanized synthetic protocells contribute to making 3D bioprinted tissues living and functional.
Gels 05 00029 g001

Share and Cite

MDPI and ACS Style

Blaeser, A.; Heilshorn, S.C.; Duarte Campos, D.F. Smart Bioinks as de novo Building Blocks to Bioengineer Living Tissues. Gels 2019, 5, 29. https://doi.org/10.3390/gels5020029

AMA Style

Blaeser A, Heilshorn SC, Duarte Campos DF. Smart Bioinks as de novo Building Blocks to Bioengineer Living Tissues. Gels. 2019; 5(2):29. https://doi.org/10.3390/gels5020029

Chicago/Turabian Style

Blaeser, Andreas, Sarah C. Heilshorn, and Daniela F. Duarte Campos. 2019. "Smart Bioinks as de novo Building Blocks to Bioengineer Living Tissues" Gels 5, no. 2: 29. https://doi.org/10.3390/gels5020029

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop